FDA Artificial Intelligence Faces Scrutiny Over Fake Drug Study Citations

What Happened

CNN reports that the US Food and Drug Administration has employed artificial intelligence to streamline and accelerate the drug approval process. However, some of the FDA\’s AI-generated reports have included citations to research studies that do not actually exist. The use of fabricated references in critical regulatory documents has triggered concern among scientific and medical professionals. The FDA had intended for the AI to assist reviewers by quickly analyzing vast amounts of scientific data around new drugs entering the market.

Why It Matters

The discovery of non-existent research citations in FDA AI reports highlights serious challenges in using artificial intelligence for high-stakes regulatory work. It calls into question the reliability and oversight of AI in life sciences and health sectors, fueling debates about best practices for AI deployment in critical government functions. Governments and tech companies worldwide will likely pay closer attention to the verification and validation processes of AI-generated content, especially for sensitive regulatory or public health decisions. Read more in our AI News Hub